Navigation Links
ACORN Expands Oncology Information Portfolio With Comprehensive Data Warehouse
Date:5/27/2008

MEMPHIS, Tenn., May 27 /PRNewswire/ -- Accelerated Community Oncology Research Network(TM) (ACORN), an oncology-focused CRO and research network, announced today its expansion of the company's aggregated information portfolio with a proprietary oncology-focused data warehouse. Integrating patient-reported outcomes (PROs), electronic medical records (EMR), claims data, and laboratory information systems, garnered from community oncology practices nationwide where 85% of cancer care is provided, ACORN's unique data warehouse offers reliable information solutions to payers, financial institutions, pharmaceutical / biotech companies, and community oncology practices.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071112/CLM151LOGO )

With the recent announcement of the company's accrual of over one million comprehensive physical and psychological cancer patient assessments obtained via the Patient Assessment Care and Education (PACE) System PACE(TM) and continued market uptake of Guardian EDC(TM) (web-based electronic data capture), ACORN(TM) continues to demonstrate leadership in capturing unique electronic data into a single platform for easy access across the full range of data elements and conducting scientific analysis to generate reliable information solutions in the oncology industry.

According to CEO, Steve Coplon, "We are not just the purveyors of data; we analyze it, and provide solutions through our multimodal capabilities. Our national network of oncologists, nurses, and practice administrators works closely with our PhD statisticians, psychologists, and health economists on staff to conduct unique analysis which has been well received across multiple industries. ACORN's data warehouse has reached critical mass in that it now provides a representative sample of most cancer types and treatment regimens. Many pharmaceutical, biotech, insurance companies, and others have been pleased with our ability to answer important questions on a whole array of cancer and quality of life issues. This is achieved by having a diverse and full complement of reliable data sets that are assessed and analyzed by our experienced scientific team."

ACORN's unique data warehouse enables pharmacoeconomic and health outcomes analysis previously unachievable. "In addition to traditional sources of information, we have a unique component in our PACE PRO gathering capability which allows us to scientifically analyze patients' symptom burden and quality of life," states Mark Walker, PhD, Director of Scientific Management. "Historically, the analysis of treatments and outcomes, either clinical or economic across different patient populations, has not included rigorous measurements of patient-reported outcomes, both physical and psychological. In addition, Pharma and payer sectors are finding increased value from ACORN's immediate access to hundreds of thousands of oncology patients."

Analytical results are routinely published in peer-reviewed journals and presented at major scientific meetings. For additional information visit http://www.ACORNresearch.net or contact Liz Conway, Director of Marketing and Corporate Services, 901-259-0878.

Accelerated Community Oncology Research Network, Inc. (ACORN) ACORN focuses on oncology exclusively. ACORN offers centralized clinical trial services, scientific analysis, and is a full-service Clinical Research Organization (CRO), providing contract and budgeting services; fostering accrual of subjects at the site level; collecting data and monitoring its accuracy; and working seamlessly with both trial sponsors and participating practices.

Contact Information:

Liz Conway

(901) 435-5570

lconway@sosacorn.com

http://www.ACORNresearch.net

Deborah D. Coble

901-683-0055x1312

Cell: 901-831-1010

dcoble@sosacorn.com


'/>"/>
SOURCE Accelerated Community Oncology Research Network
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Accelerated Community Oncology Research Network, Inc. (ACORN), Initiates a Phase 2b Metastatic Breast Cancer Trial in Cooperation With Bayer and Onyx
2. Acorn Acquisition Corp Announces Definitive Agreement to Acquire Lumen Medical Inc.
3. DuPont Expands Animal Health Solutions Business in Asia
4. Hospira Expands Board of Directors
5. Sidec AB Expands Into New Offices
6. Angiotech Expands Quill(TM) SRS product offering receiving FDA 510(k) approval for smaller size diameters of Quill(TM) SRS PDO
7. SAFC Hitech(TM) Expands Sheboygan Facility With State-of-the-Art Manufacturing Cleanroom
8. Quintiles Consulting Business Expands
9. REVISED: BrainCells Inc. Expands Series B Financing to $50 Million
10. BrainCells Inc. Expands Series B Financing to $50 Million
11. Pacira Pharmaceuticals, Inc. Expands Development Collaborations for DepoFoam(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)...  Sequenom, Inc. (NASDAQ: SQNM ), a ... the development of innovative products and services, announced today ... States denied its petition to review decisions ... U.S. Patent No. 6,258,540 (",540 Patent") are not patent ... Supreme Court,s Mayo Collaborative Services v. Prometheus Laboratories decision.  ...
(Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
(Date:6/24/2016)... Raleigh, NC (PRWEB) , ... June 24, 2016 , ... ... find the most commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings ... here to read it now. , Diagnostic biomarkers are signposts in the blood, ...
(Date:6/23/2016)... , June 23, 2016 A person commits a ... crime scene to track the criminal down. An ... Food and Drug Administration (FDA) uses DNA evidence to track ... Sound far-fetched? It,s not. The FDA has increasingly ... support investigations of foodborne illnesses. Put as simply as possible, ...
Breaking Biology Technology:
(Date:6/21/2016)... June 21, 2016 NuData Security announced today ... role of principal product architect and that ... of customer development. Both will report directly to ... The moves reflect NuData,s strategic growth in its ... high customer demand and customer focus values. ...
(Date:6/16/2016)... The global Biometric ... USD 1.83 billion by 2024, according to a ... proliferation and increasing demand in commercial buildings, consumer ... the market growth.      (Logo: ... of advanced multimodal techniques for biometric authentication and ...
(Date:6/9/2016)... ISTANBUL , June 9, 2016  Perkotek an innovation leader in attendance control ... to seamlessly log work hours, for employers to make sure the right employees are ... Logo - http://photos.prnewswire.com/prnh/20160609/377486LOGO ... ... ...
Breaking Biology News(10 mins):